Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Return on Equity (2016 - 2025)

Amicus Therapeutics' Return on Equity history spans 15 years, with the latest figure at 0.11% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity rose 19.0% year-over-year to 0.11%, compared with a TTM value of 0.11% through Dec 2025, up 19.0%, and an annual FY2025 reading of 0.12%, up 20.0% over the prior year.
  • Return on Equity for Q4 2025 was 0.11% at Amicus Therapeutics, down from 0.06% in the prior quarter.
  • The five-year high for Return on Equity was 0.06% in Q3 2025, with the low at 1.85% in Q4 2022.
  • Average Return on Equity over 5 years is 0.95%, with a median of 0.97% recorded in 2021.
  • Year-over-year, Return on Equity tumbled -112bps in 2022 and then surged 86bps in 2025.
  • Tracing FOLD's Return on Equity over 5 years: stood at 0.73% in 2021, then tumbled by -153bps to 1.85% in 2022, then skyrocketed by 44bps to 1.03% in 2023, then soared by 71bps to 0.3% in 2024, then skyrocketed by 64bps to 0.11% in 2025.
  • Per Business Quant, the three most recent readings for FOLD's Return on Equity are 0.11% (Q4 2025), 0.06% (Q3 2025), and 0.19% (Q2 2025).